148 related articles for article (PubMed ID: 402280)
1. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
2. Serum calcitonin response to induced hypercalcemia.
Telenius-Berg M; Almqvist S; Wästhed B
Acta Med Scand; 1975 May; 197(5):367-75. PubMed ID: 1146615
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin.
McLean GW; Rabin D; Moore L; Deftos LJ; Lorber D; McKenna TJ
Metabolism; 1984 Sep; 33(9):790-6. PubMed ID: 6472115
[TBL] [Abstract][Full Text] [Related]
4. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
[TBL] [Abstract][Full Text] [Related]
5. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type II: the role of gastrointestinal humoral factors in calcitonin release following alcohol and pentagastrin stimulation.
Fletcher DR; Gamvros O; Man WK; Ahmed Y; Trayner I; Adrian T
Aust N Z J Surg; 1984 Jun; 54(3):271-5. PubMed ID: 6147130
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
Starling JR; Harris C; Granner DK
Arch Surg; 1978 Mar; 113(3):241-3. PubMed ID: 637688
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
9. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
10. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
11. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
Gordin A; Lamberg BA; Pelkonen R; Almqvist S
Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
[TBL] [Abstract][Full Text] [Related]
13. The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II.
Wells SA; Ontjes DA; Cooper CW; Hennessy JF; Ellis GJ; McPherson HT; Sabiston DC
Ann Surg; 1975 Oct; 182(4):362-70. PubMed ID: 1180576
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.
Schifter S
Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454
[TBL] [Abstract][Full Text] [Related]
15. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
Graham SM; Genel M; Touloukian RJ; Barwick KW; Gertner JM; Torony C
J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
[TBL] [Abstract][Full Text] [Related]
16. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
[TBL] [Abstract][Full Text] [Related]
18. Letter: Calcitonin release provoked by intravenous pentagastrin in medullary carcinoma of thyroid.
Moers AM; Mulder H; Su CA; Visser JL; van de Wiel TW
Lancet; 1975 May; 1(7914):1035. PubMed ID: 48705
[No Abstract] [Full Text] [Related]
19. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
Rude RK; Singer FR
J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]